Attached files

file filename
EX-99.2 - EXHIBIT 99.2 - AVADEL PHARMACEUTICALS PLCv434096_ex99-2.htm
EX-99.1 - EXHIBIT 99.1 - AVADEL PHARMACEUTICALS PLCv434096_ex99-1.htm

  

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________

 

FORM 8-K

___________________

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 8, 2016

___________________

 

FLAMEL TECHNOLOGIES S.A.

(Exact name of registrant as specified in its charter)

___________________

 

Republic of France
(State or Other Jurisdiction
of Incorporation) 

000-28508
(Commission File Number)

98-0639540

(I.R.S. Employer
Identification No.)

 

Parc Club du Moulin à Vent
33, avenue du Docteur Georges Levy
69200 Vénissieux France 

(Address of Principal Executive Offices)

 

 

 

Not Applicable

(Zip Code) 

 

Registrant’s telephone number, including area code: 011 +33 472 78 34 34

___________________

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

£Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
£Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
£Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  
£Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

 

 

Item 7.01Regulation FD Disclosure.

 

On March 14, 2016, Flamel Technologies S.A. (the “Company”) intends to make a presentation at the 28th Annual ROTH Conference in Dana Point, California. A copy of the Company’s complete slide presentation to be used at the Conference is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. As previously announced, the Company’s presentation will be webcast live and can be accessed by visiting the Investor section of the Company’s website at http://www.flamel.com/investors. A replay of the presentation, together with the complete slide presentation, will also be available and archived for at least 30 days on the website following the event.

 

The information responsive to Item 7.01 of this Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as may be expressly set forth by specific reference in such a filing.

 

Item 8.01Other Events.

 

On March 8, 2016, the Company issued a press release, a copy of which is furnished as Exhibit 99.2 to this current report on Form 8-K and is incorporated herein by reference.

 

Item 9.01Financial Statements and Exhibits.

 

(d)Exhibits

 

99.1   Form of Slide Presentation of Flamel Technologies S.A. as of March 14, 2016.
99.2   Press release of Flamel Technologies S.A. dated as of March 8, 2016

  

 

 2 

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  FLAMEL TECHNOLOGIES S.A.
       
  By: /s/ Phillandas T. Thompson  
    Phillandas T. Thompson  
    Senior Vice President, General Counsel and Corporate Secretary  

Date: March 14, 2016

 

 

 3 

 

 

Exhibit Index

  

99.1   Form of Slide Presentation of Flamel Technologies S.A. as of March 14, 2016.
99.2   Press release of Flamel Technologies S.A. dated as of March 8, 2016